SCHEMBL7787410

SCHEMBL7787410

CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)Oc1ccc(CCC(=O)OCI)cc1OC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C.O=C(O)OCI

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 3/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.42
CA5A P35218 1/20 0.42
CTSL P07711 4/20 0.42
CTSB P07858 4/20 0.42
CTSS P25774 3/20 0.42
CTSK P43235 3/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CAPN1 P07384 1/20 0.40
LMNA P02545 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRA2A P08913 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA2C P18825 1/20 0.39
DRD1 P21728 1/20 0.39
ADRA1A P35348 1/20 0.39
DRD3 P35462 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7791790 0.93 CTSL (0.48) CASP1CA1CTSLCTSBCTSS
SCHEMBL3740295 0.88 CASP1 (0.46) CASP1CA1CA2CA5ACTSL
SCHEMBL3734188 0.86 FFAR4 (0.49) CASP1CA1CA2CA5ACTSL
SCHEMBL3727193 0.86 CTSD (0.49) CASP1CA1CA2CA5ACTSL
SCHEMBL7790683 0.85 CASP1 (0.46) CASP1CA1CA2CA5ACTSL
SCHEMBL3728055 0.80 CTSL (0.53) CASP1CTSLCTSBCTSSCTSK
SCHEMBL3731564 0.78 CTSB (0.51) CASP1CA2CA5ACTSLCTSB
SCHEMBL13077574 0.78 CTSL (0.47) CASP1CA2CA5ACTSLCTSB
SCHEMBL7791929 0.77 CTSD (0.44) CASP1CTSLCTSSCTSKCTSD
SCHEMBL13077457 0.77 CTSL (0.47) CASP1CA2CA5ACTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150956-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MEDIVIR AB (SE) 2001-11-07 EP disclosed
WO-2000047561-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MEDIVIR AB (SE) 2000-08-17 WO disclosed